Compare CAVA Group Inc (CAVA) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CAVA Group Inc vs Neurocrine Biosciences Inc — how do they compare? CAVA Group Inc trades at $69.69 (market cap $8.45B), while Neurocrine Biosciences Inc trades at $170.05 (market cap $17.51B). The key difference: Neurocrine Biosciences Inc is far larger — about 2.1× CAVA Group Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, CAVA Group Inc nearer its low. Which is the better fit depends on your goals.
| CAVA | NBIX | |
|---|---|---|
Market Cap | $8.45B | $17.51B |
Sector | Consumer Cyclical | Health |
52-Week High | $97.39 | $180.55 |
52-Week Low | $43.59 | $123.10 |
Enterprise Value | $8.54B | $16.60B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CAVA Group Inc
CAVA is a Mediterranean fast-casual restaurant brand in the US. It offers customizable bowls, salads, and pitas featuring healthy ingredients, while also selling its signature dips and dressings in grocery stores.
Read more on CAVA →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
